Company

ST3 Development Corporation was founded in 2002 to develop commercial bioreactor systems for tissue-engineered medical product (TEMP) manufacturing. The company builds on key staff's previous experience developing three-dimensional construct bioreactor systems for the research market and specialty test equipment for the medical device market. Employing experts in mechanical, electrical, software and biomedical engineering, we create advanced tissue-organ manufacturing bioreactors that are scalable and GMP-compliant.

The founders have been developing bioreactors for engineered tissues since 2000 with the introduction of the ITEMS bioreactor product line under EnduraTEC Systems Corporation, founded in 1990 as a mechanical test instrument manufacturer, that was sold to Bose Corporation in 2004. A broad bioreactor product portfolio was launched in 2004 under Tissue Growth Technologies Corporation, a bioreactor development company, that was sold to Instron in 2012. While previous bioreactor designs catered to academic research needs, ST3’s mission is the development of commercial bioreactors for TEMPs to advance manufacturing.